ImageneBio (IMA) Free Cash Flow (2020 - 2025)
ImageneBio's (IMA) quarterly Free Cash Flow came in at -$26.6 million in Q3 2025, down 305.54% year-on-year from $13.0 million in Q3 2024, and down 294.46% quarter-over-quarter from -$6.8 million in Q2 2025.
ImageneBio (IMA) Free Cash Flow (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Free Cash Flow across 6 years of filings, most recently posting -$26.6 million for Q3 2025.
- Free Cash Flow for Q3 2025 came in at -$26.6 million, down 305.54% year-over-year; the trailing twelve-month figure through Dec 2025 was -$40.6 million (up 11.69% YoY), and the FY2024 annual result was -$46.0 million, up 42.61% from the prior year.
- Free Cash Flow came in at -$26.6 million for Q3 2025 at ImageneBio, down from -$6.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $13.0 million in Q3 2024 to a low of -$28.2 million in Q4 2024.
- The 5-year median for Free Cash Flow is -$18.1 million (2023), against an average of -$16.0 million.
- Across the five-year window, Free Cash Flow soared 164.82% in 2024 and plunged 305.54% in 2025, its largest moves.
- ImageneBio's Free Cash Flow stood at -$15.0 million in 2021, then dropped by 11.12% to -$16.7 million in 2022, then sank by 32.11% to -$22.1 million in 2023, then dropped by 27.53% to -$28.2 million in 2024, then climbed by 5.39% to -$26.6 million in 2025.
- The last three Free Cash Flow figures came in at -$26.6 million (Q3 2025), -$6.8 million (Q2 2025), and -$7.2 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -26.64 Mn |
| Sep 30, 2025 | -26.64 Mn |
| Jun 30, 2025 | -6.75 Mn |
| Jun 30, 2025 | -6.75 Mn |
| Mar 31, 2025 | -7.23 Mn |
| Mar 31, 2025 | -7.23 Mn |
| Dec 31, 2024 | -28.16 Mn |
| Dec 31, 2024 | -28.16 Mn |
| Sep 30, 2024 | 12.96 Mn |
| Sep 30, 2024 | 12.96 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Mar 31, 2024 | -18.30 Mn |
| Mar 31, 2024 | -18.30 Mn |
| Dec 31, 2023 | -22.08 Mn |
| Dec 31, 2023 | -22.08 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Jun 30, 2023 | -18.14 Mn |
| Jun 30, 2023 | -18.14 Mn |